• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCTα 是一种用于诊断喉鳞状细胞癌的新型生物标志物。

CCT α is a novel biomarker for diagnosis of laryngeal squamous cell cancer.

机构信息

Department of Otolaryngology-Head and Neck Surgery, The Second Hospital of Jilin University, 218 Ziqiang Street, Changchun, 130041, China.

Department of Otolaryngology-Head and Neck Surgery, The Central Hospital of Wuhan, 26 Shengli Street, Wuhan, 430014, China.

出版信息

Sci Rep. 2019 Aug 14;9(1):11823. doi: 10.1038/s41598-019-47895-x.

DOI:10.1038/s41598-019-47895-x
PMID:31413263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6694151/
Abstract

Choline phosphate-based delivery systems can target the acidic tumor microenvironment. In this study, we set out to evaluate the diagnostic value of Choline phosphate cytidylyltransferase-α (CCTα) in laryngeal squamous cell cancer (LSCC). The expression of CCTα was detected using immunohistochemistry in 50 LSCC patients' tissues and 16 vocal polyps as control group. Then, clinical data was collected and we used receiver operating characteristic curve (ROC) to estimate the potential of CCTα as diagnostic biomarker. We found CCTα levels to be significantly high in the tissues derived from LSCC patients, (p < 0.001). Further, we observed a positive correlation of CCTα with tumor size (p < 0.001), TNM stage (p < 0.001), lymph node metastasis (p < 0.001) as well as the grade of LSCC malignancy (p < 0.001). Furthermore, AUC was determined to be 0.939 by ROC, and the optimal cutoff value 3.100, with 76.0% sensitivity and 100% specificity. We also found an epigenetic basis of CCTα over-expression in LSCC tissues with significantly reduced methylation of CCTα in LSCC tissues, compared to vocal polyps (p < 0.001). These results support epigenetically-induced over-expression of CCTα as a potential diagnostic marker for LSCC.

摘要

基于磷酸胆碱的递药系统可以靶向酸性肿瘤微环境。在本研究中,我们旨在评估磷酸胆碱胞苷酰转移酶-α(CCTα)在喉鳞状细胞癌(LSCC)中的诊断价值。采用免疫组织化学法检测 50 例 LSCC 患者组织和 16 例声带息肉(对照组)中 CCTα 的表达。然后收集临床资料,采用受试者工作特征曲线(ROC)估计 CCTα 作为诊断生物标志物的潜力。结果发现,LSCC 患者组织中 CCTα 水平显著升高(p<0.001)。进一步观察到 CCTα 与肿瘤大小(p<0.001)、TNM 分期(p<0.001)、淋巴结转移(p<0.001)以及 LSCC 恶性程度分级(p<0.001)呈正相关。ROC 曲线确定 AUC 为 0.939,最佳截断值为 3.100,灵敏度为 76.0%,特异性为 100%。我们还发现 LSCC 组织中 CCTα 表达的表观遗传学基础,与声带息肉相比,LSCC 组织中 CCTα 的甲基化显著降低(p<0.001)。这些结果支持 CCTα 的表观遗传诱导过表达作为 LSCC 的潜在诊断标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ff/6694151/6acfdc3b709d/41598_2019_47895_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ff/6694151/577f9dff07d5/41598_2019_47895_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ff/6694151/02b0b4aef9ff/41598_2019_47895_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ff/6694151/7ff50238932b/41598_2019_47895_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ff/6694151/866e5ec920f7/41598_2019_47895_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ff/6694151/6acfdc3b709d/41598_2019_47895_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ff/6694151/577f9dff07d5/41598_2019_47895_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ff/6694151/02b0b4aef9ff/41598_2019_47895_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ff/6694151/7ff50238932b/41598_2019_47895_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ff/6694151/866e5ec920f7/41598_2019_47895_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ff/6694151/6acfdc3b709d/41598_2019_47895_Fig5_HTML.jpg

相似文献

1
CCT α is a novel biomarker for diagnosis of laryngeal squamous cell cancer.CCTα 是一种用于诊断喉鳞状细胞癌的新型生物标志物。
Sci Rep. 2019 Aug 14;9(1):11823. doi: 10.1038/s41598-019-47895-x.
2
Choline phosphate cytidylyltransferase-α is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas.胆碱磷酸胞苷转移酶-α是一种新型抗原,可被抗 ERCC1 抗体 8F1 检测到,对肺癌和头颈部鳞状细胞癌患者具有生物标志物价值。
Cancer. 2014 Jun 15;120(12):1898-907. doi: 10.1002/cncr.28643. Epub 2014 Apr 1.
3
Diagnostic and Prognostic Value of Fibrinogen, Fibrinogen Degradation Products, and Lymphocyte/Monocyte Ratio in Patients With Laryngeal Squamous Cell Carcinoma.纤维蛋白原、纤维蛋白降解产物和淋巴细胞/单核细胞比值对喉鳞状细胞癌患者的诊断和预后价值。
Ear Nose Throat J. 2024 May;103(5):NP278-NP288. doi: 10.1177/01455613211048970. Epub 2021 Oct 21.
4
Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.开发和验证用于预测喉鳞状细胞癌患者生存的表观遗传特征。
DNA Cell Biol. 2021 Feb;40(2):247-264. doi: 10.1089/dna.2020.5789. Epub 2021 Jan 21.
5
Spondin-2 is a novel diagnostic biomarker for laryngeal squamous cell carcinoma.Spondin-2是一种用于喉鳞状细胞癌的新型诊断生物标志物。
Pathol Res Pract. 2019 Feb;215(2):286-291. doi: 10.1016/j.prp.2018.11.017. Epub 2018 Nov 29.
6
[Correlation of Rab coupling protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].[Rab偶联蛋白表达与喉鳞状细胞癌临床病理特征及预后的相关性]
Zhonghua Zhong Liu Za Zhi. 2015 Feb;37(2):101-6.
7
Clinical diagnostic value of amino acids in laryngeal squamous cell carcinomas.喉鳞状细胞癌中氨基酸的临床诊断价值。
PeerJ. 2023 Jun 1;11:e15469. doi: 10.7717/peerj.15469. eCollection 2023.
8
Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.波形蛋白(VIM)和转移相关蛋白 1(MTA1)在喉鳞状细胞癌中的表达与患者的预后结果相关。
Am J Otolaryngol. 2019 Jul-Aug;40(4):487-493. doi: 10.1016/j.amjoto.2019.04.002. Epub 2019 Apr 3.
9
Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.Cyr61/CCN1过表达诱导上皮-间质转化,导致喉肿瘤侵袭、转移及预后不良。
Asian Pac J Cancer Prev. 2015;16(7):2659-64. doi: 10.7314/apjcp.2015.16.7.2659.
10
The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma.Claudin-11 启动子高甲基化在喉鳞状细胞癌中的临床意义。
Med Sci Monit. 2017 Jul 26;23:3635-3640. doi: 10.12659/msm.904751.

引用本文的文献

1
TCP1 promotes the progression of malignant tumours by stabilizing c-Myc through the AKT/GSK-3β and ERK signalling pathways.TCP1通过AKT/GSK-3β和ERK信号通路稳定c-Myc,从而促进恶性肿瘤的进展。
Commun Biol. 2025 Apr 4;8(1):563. doi: 10.1038/s42003-025-07867-6.
2
Chaperonin-containing TCP-1 subunit genes are potential prognostic biomarkers and are correlated with Th2 cell infiltration in lung adenocarcinoma: An observational study.热休克蛋白 10 同源蛋白(TCP-1)复合物亚基基因是潜在的预后生物标志物,并与肺腺癌中 Th2 细胞浸润相关:一项观察性研究。
Medicine (Baltimore). 2024 May 31;103(22):e38387. doi: 10.1097/MD.0000000000038387.
3

本文引用的文献

1
Targeting protein methylation: from chemical tools to precision medicines.靶向蛋白质甲基化:从化学工具到精准药物。
Cell Mol Life Sci. 2019 Aug;76(15):2967-2985. doi: 10.1007/s00018-019-03147-9. Epub 2019 May 18.
2
DNA methylation at an enhancer of the three prime repair exonuclease 2 gene (TREX2) is linked to gene expression and survival in laryngeal cancer.三引物修复外切核酸酶 2 基因(TREX2)增强子的 DNA 甲基化与喉癌中的基因表达和存活有关。
Clin Epigenetics. 2019 May 3;11(1):67. doi: 10.1186/s13148-019-0666-5.
3
Cancer statistics, 2019.
Emergence of Lipid Droplets in the Mechanisms of Carcinogenesis and Therapeutic Responses.
脂滴在肿瘤发生机制及治疗反应中的出现
Cancers (Basel). 2023 Aug 14;15(16):4100. doi: 10.3390/cancers15164100.
4
Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation.CCT-3的上调通过miR-223竞争和Wnt/β-连环蛋白信号通路激活诱导乳腺癌细胞增殖。
Front Oncol. 2020 Sep 24;10:533176. doi: 10.3389/fonc.2020.533176. eCollection 2020.
癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
4
Incidence and mortality of laryngeal cancer in China, 2008-2012.2008 - 2012年中国喉癌的发病率和死亡率
Chin J Cancer Res. 2018 Jun;30(3):299-306. doi: 10.21147/j.issn.1000-9604.2018.03.02.
5
Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation.喉鳞状细胞癌中 PCDH17 肿瘤抑制因子的反复转录缺失部分是由异常启动子 DNA 甲基化介导的。
Mol Carcinog. 2018 Jul;57(7):878-885. doi: 10.1002/mc.22808. Epub 2018 Apr 6.
6
Editorial: Cancer Epigenetics.社论:癌症表观遗传学
Curr Cancer Drug Targets. 2018;18(1):3-4. doi: 10.2174/156800961801171208144307.
7
Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.喉鳞状细胞癌中PTPRD肿瘤抑制因子的复发表观遗传沉默。
Tumour Biol. 2017 Mar;39(3):1010428317691427. doi: 10.1177/1010428317691427.
8
ELMO3 predicts poor outcome in T1 laryngeal cancer.ELMO3可预测T1期喉癌的不良预后。
Clin Otolaryngol. 2017 Dec;42(6):1181-1186. doi: 10.1111/coa.12845. Epub 2017 Mar 13.
9
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
10
Correlation between levels of expression of minichromosome maintenance proteins, Ki-67 proliferation antigen and metallothionein I/II in laryngeal squamous cell cancer.喉鳞状细胞癌中微小染色体维持蛋白、Ki-67增殖抗原及金属硫蛋白I/II表达水平之间的相关性
Int J Oncol. 2016 Feb;48(2):635-45. doi: 10.3892/ijo.2015.3273. Epub 2015 Nov 27.